ACG acquires significant stake in IQGEN-X EP News Bureau Nov 3, 2020 The investment is aimed at augmenting R&D and IP in drug development
Long HCC pipeline marks change for previously stagnant market EP News Bureau Nov 3, 2020 Many new therapies entering the market have different mechanisms of action (MOA) and are aiming to meet needs in different…
Scientists develop faster method to detect antibiotic resistance EP News Bureau Nov 3, 2020 New the technique uses nanotechnology to identify antibiotic resistance in approximately 45 minutes
Equine polyclonal antibodies have shown higher potency in in-vitro studies of SARS-CoV-2 virus… Usha Sharma Nov 3, 2020 Bharat Serums and Vaccines has initiated a research project to co-develop an equine polyclonal antibody, along with NIV, against…
Zydus Cadila files IND application for ZYIL1, NLRP3 inflammasome inhibitor EP News Bureau Nov 3, 2020 It can selectively modulate the inflammatory responses caused by the ‘Cytokine Storm’ in ARDS, COVID19 and other inflammatory…
Experts seek data on remdesivir and COVID-19 treatment-related products Usha Sharma Nov 3, 2020 Ask for details of specific indications for which approval has been granted, any conditions or restrictions attached to the…
The Eppendorf Way to Do it: Move It Adjustable Spacing Pipettes EP News Bureau Nov 3, 2020 Move It is available with 4,6,8, and 12 channels, mechanical or electronic
CEPI extends partnership with Clover Biopharma to fund COVID-19 vaccine candidate EP News Bureau Nov 3, 2020 CEPI to fund the development of Clover’s protein-based S-Trimer vaccine candidate through to licensure, including a global pivotal…
Zydus to present PBC and NASH clinical trial data of Saroglitazar Mg at AASLD event EP News Bureau Nov 2, 2020 The Liver Meeting Digital Experience 2020 is taking place virtually from November 13-16, 2020
Reducing API dependence: Have we got the strategy right? EP News Bureau Nov 2, 2020 Reji K Joseph, Associate Professor, Institute for Studies in Industrial Development, New Delhi explains that the PLI scheme has…